Evidence map›Paper›PMID 42427554›Full record

ArticlebioRxiv : the preprint server for biology2026

Molecular mechanism of IF1- and IF2-driven translation initiation in bacteria.

Gabriel Soares Guerra, Hassan Zafar, Xueliang Ge, Ritwika S Basu, Chenhui Huang, Ahmed H Hassan, Nicolette A Valdez, Sylva Brabencova, Lucie Slamova, Chandra Sekhar Mandava and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gabriel Soares GuerraCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-5277-5938
Hassan ZafarCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.
Xueliang GeDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-7954-3195
Ritwika S BasuDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0001-6410-7905
Chenhui HuangDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.
Ahmed H HassanCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0001-8463-8877
Nicolette A ValdezDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Sylva BrabencovaCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0009-0003-6727-2174
Lucie SlamovaCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.
Chandra Sekhar MandavaDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-3028-3270
Howard GamperDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0001-9007-8546
Ya-Ming HouDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.ORCID 0000-0001-6546-2597
Matthieu G GagnonDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0003-4516-604X
Suparna SanyalDepartment of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-7124-792X
Gabriel DemoCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-5472-9249

Funding

tRNA in codon usageR35GM134931 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI HOU, YA-MING · 2020 to 2025
$5.4M
Structural Basis for the Allosteric Mechanisms Regulating Ribosome FunctionR01GM136936 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GAGNON, MATTHIEU · 2020 to 2024
$1.8M
The New Houston Area Molecular Biophysics ProgramT32GM150582 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI THEODORE G WENSEL · 2025 to 2026
$1.2M
Structural bases for protein synthesis quality controlR35GM158272 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MATTHIEU GAGNON · 2025 to 2026
$817k
NIGMS NIH HHS R01 GM136936NIGMS NIH HHS R35 GM134931NIGMS NIH HHS R35 GM158272NIGMS NIH HHS T32 GM150582
6 · The paper itself

Abstract

Bacterial translation initiation is a highly regulated process essential for accurate start codon selection and the assembly of an elongation-competent ribosome. Two initiation factors, 1 (IF1) and 3 (IF3), contribute to quality control for formation of 30S preinitiation complex (30S PIC), while the GTPase IF2 facilitates stable initiator tRNA binding and promotes subunit association. However, the molecular mechanism of IF1 action and the regulatory role of IF2-mediated GTP hydrolysis and inorganic phosphate (Pi) release remain poorly understood. Using ensemble cryo-EM integrated with fast-kinetics, we delineate the translation initiation pathway involving IF1 and IF2. We show that IF1 transiently associates with the 30S subunit and interferes with the formation of multiple inter-subunit bridges. IF2 promotes subunit association by stabilizing the 30S PIC through interactions mediated by its N-terminal domains. IF1 departure happens after or concomitant with GTP hydrolysis, following which the inter-subunit bridges establish. Then Pi release triggers remodeling of IF2 followed by its departure from the 70S initiation complex. These findings reveal how the coordinated interplay of IF1 and IF2 with the ribosome ensures translational fidelity and plays crucial role for formation of elongation-competent 70S.

Indexed as

ensemble cryo-EMGTP hydrolysisinitiation factor 1 (IF1)initiation factor 2 (IF2)Translation initiation

Identifiers

PMID42427554
PMCPMC13345285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.